Stockscreener 앱 받기
7.30
1.67%
0.12
전일 마감가:
$7.18
열려 있는:
$7.23
하루 거래량:
5,031
Relative Volume:
0.16
시가총액:
$13.72M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-6.29%
1개월 성능:
-14.12%
6개월 성능:
+42.02%
1년 성능:
+0.00%
1일 변동 폭
$7.1504
$7.307
1주일 범위
$6.815
$7.99
52주 변동 폭
$2.90
$12.55
Neuphoria Therapeutics Inc Stock (NEUP) Company Profile
명칭
Neuphoria Therapeutics Inc
전화
781-439-5551
주소
100 SUMMIT DR, BURLINGTON
NEUP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NEUP
Neuphoria Therapeutics Inc
|
7.30 | 14.64M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.95 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
575.50 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
445.81 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
684.44 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
311.20 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Neuphoria Therapeutics Inc Stock (NEUP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-09-28 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2023-09-28 | 재확인 | Maxim Group | Buy |
| 2022-01-10 | 개시 | Berenberg | Buy |
| 2022-01-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-01-10 | 개시 | Evercore ISI | Outperform |
| 2022-01-10 | 개시 | H.C. Wainwright | Buy |
모두보기
Neuphoria Therapeutics Inc 주식(NEUP)의 최신 뉴스
Volatility clustering patterns for Neuphoria Therapeutics Inc.Gap Down & Fast Moving Stock Watchlists - Newser
Sentiment analysis tools applied to Neuphoria Therapeutics Inc.July 2025 Volume & High Accuracy Swing Entry Alerts - Newser
Chart based exit strategy for Neuphoria Therapeutics Inc.Quarterly Portfolio Report & Long-Term Investment Growth Plans - Newser
Exit strategy if you’re trapped in Neuphoria Therapeutics Inc.July 2025 Breakouts & Capital Protection Trading Alerts - Newser
Is Neuphoria Therapeutics Inc. reversing from oversold territoryFed Meeting & Low Drawdown Trading Strategies - Newser
Is it too late to sell Neuphoria Therapeutics Inc.2025 Price Action Summary & Free Long-Term Investment Growth Plans - Newser
Is Neuphoria Therapeutics Inc. stock entering bullish territoryNew Guidance & Free Accurate Trade Setup Notifications - Newser
How to build a dashboard for Neuphoria Therapeutics Inc. stockPortfolio Gains Summary & Target Return Focused Stock Picks - Newser
Can momentum traders help lift Neuphoria Therapeutics Inc.Risk Management & Daily Profit Maximizing Tips - Newser
Statistical indicators supporting Neuphoria Therapeutics Inc.’s strengthJuly 2025 News Drivers & Intraday High Probability Setup Alerts - Newser
What to expect from Neuphoria Therapeutics Inc. in the next 30 daysPortfolio Growth Summary & Fast Gaining Stock Strategy Reports - Newser
Identifying reversal signals in Neuphoria Therapeutics Inc.2025 Stock Rankings & Free AI Powered Buy and Sell Recommendations - Newser
Will breakout in Neuphoria Therapeutics Inc. lead to full recoveryProfit Target & Free High Return Stock Watch Alerts - Newser
Neuphoria Therapeutics Inc. stock trend outlook and recovery path2025 Risk Factors & Consistent Profit Trading Strategies - Newser
Analyzing Neuphoria Therapeutics Inc. with multi timeframe charts2025 Major Catalysts & Technical Entry and Exit Tips - Newser
What momentum shifts mean for Neuphoria Therapeutics Inc.CPI Data & AI Powered Buy and Sell Recommendations - Newser
How hedge fund analytics apply to Neuphoria Therapeutics Inc. stock2025 Growth vs Value & Fast Exit and Entry Strategy Plans - Newser
Neuphoria Therapeutics Inc. stock momentum explained2025 Support & Resistance & Momentum Based Trading Signals - Newser
Forecasting Neuphoria Therapeutics Inc. price range with options dataPortfolio Risk Summary & Expert Curated Trade Setup Alerts - Newser
Evaluating Neuphoria Therapeutics Inc. with trendline analysisPortfolio Growth Summary & Weekly Sector Rotation Insights - Newser
Will Neuphoria Therapeutics Inc. continue its uptrend2025 Performance Recap & Real-Time Chart Breakout Alerts - Newser
How to integrate Neuphoria Therapeutics Inc. into portfolio analysis tools2025 Support & Resistance & High Yield Stock Recommendations - Newser
Published on: 2025-08-17 00:10:08 - Newser
Why Neuphoria Therapeutics Inc. stock attracts strong analyst attentionEarnings Recap Summary & Daily Entry Point Alerts - Newser
Analyzing drawdowns of Neuphoria Therapeutics Inc. with statistical toolsPortfolio Value Report & Free Accurate Trade Setup Notifications - Newser
Live market analysis of Neuphoria Therapeutics Inc.Chart Signals & Fast Exit and Entry Trade Guides - Newser
Is Neuphoria Therapeutics Inc.’s ROIC above industry averageJuly 2025 Review & Stepwise Entry/Exit Trade Alerts - 선데이타임즈
Combining machine learning predictions for Neuphoria Therapeutics Inc.July 2025 Setups & Low Risk Profit Maximizing Plans - Newser
What MACD and RSI say about Neuphoria Therapeutics Inc.Inflation Watch & Target Return Focused Picks - Newser
Neuphoria Therapeutics Inc (NEUP) 재무 분석
Neuphoria Therapeutics Inc (NEUP)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.62%
0.21%
자본화:
|
볼륨(24시간):